Press releases
- Press releases
- Browse
Press releases
Alliance Pharma plc (AIM: APH), a speciality pharmaceutical company, is pleased to announce that it has agreed to acquire Caraderm Limited ('Caraderm') More
Significant expansion of skincare portfolio through acquisition of Hydromol dermatology range More
AGM STATEMENT More
Healthpoint Ltd. has announced that the United States Patent and Trademark Office has granted Healthpoint a Notice of Allowance on its patent application for the ointment vehicle that is the basis for Healthpoint's Xenaderm(tm). More
General Information
VITRO-BIO Pharma France
ZAC de Lavaur
63500 ISSOIRE
France
www.vitrobio.com
Founded 1994
Private ownership More
VITRO-BIO Pharma France
ZAC de Lavaur
63500 ISSOIRE
France
www.vitrobio.com
Founded 1994
Private ownership More
Foamix is partnering with leading phamaceutical companies in developing their drugs in foam formulations. The company will present at the upcoming American Academy of Dermatology meeting in New Orleans on February 18-22, 2005 More
Ness Ziona ISRAEL, April 7, 2005 - Foamix Ltd., a leader in developing innovative topical delivery systems, enters new state-of-the-art facility. More
Acrux appoints Ms Carla Gervasio Nugent as the Chief Executive Officer of its investee company Cosmeceutic Solutions. The company was set up earlier this year to develop novel skin care products for the global cosmetic markets. More
Healthpoint Ltd. has announced that the United States Patent and Trademark Office has granted Healthpoint a Notice of Allowance on its patent application for the ointment vehicle that is the basis for Healthpoint's Xenaderm(tm). More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2011 - 100 pages - $3,500
Jun 2006 - 434 pages - $2,495
Jun 2011 - 77 pages - $1,000
Sep 2011 - 117 pages - $500
Jul 2011 - 96 pages - $3,835
Dec 2007 - 49 pages - $495
May 2011 - 16 pages - $125
Nov 2009 - 142 pages - $2,350
Feb 2006 - 332 pages - $3,900
Jan 2008 - 330 pages - $4,200
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us